Everything You Wanted to Know About Cervical Surface (HPV) Testing

Did you know that a simple test could save your life? Cervical surface testing for HPV can detect the presence of the Papillomavirus (HPV) above the clinical threshold and identify the virus type. This innovative and sensitive test has an accuracy level of 92% and serves as the primary tool for early detection of pre-cancerous cells and cervical cancer. HPV PCR cervical screen replaces the traditional PAP Smear test.

Dr. Avishai Malkiel, Specialist in Obstetrics and Gynecology, Director of the Women's Health Center at Misgav Yeshayahu, Jerusalem

A woman being examined by a gynecologist

What is Cervical Cancer?

Cervical cancer is the third most common cancer among women worldwide. In Israel, 200 new cases are diagnosed each year. The cervix is located at the lower part of the uterus and protrudes into the vagina. Cancer occurs when cervical cells undergo mutations, begin to grow uncontrollably, form growths (tumors), and may even invade other body tissues.
The causes of cervical cancer are varied, but in almost all cases, there is a link between the development of the disease and the presence of the Papillomavirus. The presence of the Papillomavirus does not necessarily indicate a cancerous process, but it does require monitoring to ensure that such a process does not develop.

Early Detection Saves Lives

In most cases, pre-cancerous changes and early growths in the cervix do not come with symptoms, making regular screening tests crucial. Additionally, when there are cases of vaginal bleeding, abnormal discharge from the vagina, or bleeding during or after sexual intercourse, it is essential to seek medical advice promptly.
This test enables the early detection of changes before they evolve into a full-blown disease. The earlier the detection, the simpler the treatment and the higher the chance of survival.
Remember that early diagnosis increases the chances of successful treatment.
The risk of cervical cancer can be reduced by receiving the Papillomavirus vaccine and undergoing cervical surface testing (HPV testing) periodically, as recommended by your attending physician.

How is the Test Conducted?

The cervical surface, HPV PCR cervical screen, is performed as part of a routine gynecological examination by a gynecologist. During the examination, the doctor uses a speculum to examine the cervix and then collects cervical cells using a special brush.
The procedure itself is not painful, although you may experience some discomfort during it.
After the test, some external bleeding may occur. This bleeding is normal.
Following the examination, the samples are sent to a laboratory, where they are screened for the presence of the Papillomavirus using PCR technology.
In cases where the HPV test results are positive, the sample is sent to a pathological laboratory for a Thinprep Pap Smear test, a test that detects cells with early changes. Based on the results of both tests, your treating physician will recommend further treatment. In certain cases, the doctor may recommend performing a Thinprep Pap Smear test even if the HPV test result is negative.
It should be noted that in any case where the HPV test is positive, follow-up checks should be performed after six months to ensure that no further developments occur.

When Should Cervical Surface (HPV) Testing Be Done?

Health guidelines recommend that every woman aged 25-65 undergo cervical surface (HPV) testing once every three years, or as per the recommendation of the treating gynecologist.

  • The test is performed during a routine gynecological visit.
  • Pap smears can also be performed during pregnancy.
  • Do not undergo the test during menstrual bleeding.

If you are in the appropriate age group and have not had an HPV test or Pap smear in the last three years, please schedule an appointment with a gynecologist.
Your diligence could save your life.